prgn-3006
Precigen therapeutics
['leukemia', 'myeloid', 'prgn-3006']
precigen announces positive phase 1 dose escalation data for autologous prgn-3006 ultracar-t manufactured overnight for next day infusion in relapsed or refractory acute myeloid leukemia patients $prgn #ash22 
No investment advice. Do your own DD Market is all about taking the shares from the weak holders& providing opportunities to those that have the stamina to hold